Get Permission Priyanka A, Kaviarasan, Kannambal K, Poorana B, and Abhirami C: Clinicoepidemiological profile of steroid modified dermatophytosis following abuse of irrational combination of topical corticosteroid containing preparations (ICSP)


Introduction

Topical corticosteroids were introduced in the year 1952 by Schulzberger and Witten.1 Since then topical corticosteroids becomes most commonly used drug in dermatology practices. The clinical effects are mediated by their anti-inflammatory, vasoconstrictive, anti-proliferative and immunosuppressive properties.2 Topical corticosteroids are irrationally combined and become available as the over the counter preparations and are widely misused for various conditions. Dermatophytosis is the superficial fungal infection which is becoming resistant and difficult to treat because of inappropriate usage of irrational combination of topical corticosteroid containing preparations (ICSP). These steroid containing preparations are known to suppress the immune response against dermatophytes and also have the potential to produce a wide variety of cutaneous adverse effects. 3 In this study we aimed to highlight the adverse effects of topical steroid combination preparations abuse on fungal infection.

Aims and Objectives

To study the prevalence and factors which promotes the abuse of Irrational combination of topical corticosteroid containing preparations(ICSP) in dermatophyte infection.

Inclusion criteria

  1. Patients with the history of usage of irrational combination of topical corticosteroid containing preparations.

  2. Patients who are willing to participate in the study after getting written & informed consent.

Exclusion criteria

  1. Patients on systemic corticosteroids, antihistamines.

  2. Cosmetic preparations not mentioned any steroids on their label officially and ayurvedic preparations available in open market.

  3. Patients not willing to participate in the study and dropped out cases and irregular follow up cases.

Materials and Methods

This is a prospective observational study performed on 55 patients conducted at department of Dermatology, Venereology & Leprosy, Rajah Muthiah Medical College and Hospital, Annamalai University for a period of 2 years from Oct 2018- Sep 2020. Ethical clearance was sought from instituitional ethical committee. Patients were included according to the inclusion criteria. Present study aimed to find out the outcome of dermatophytosis following abuse of ICSP. Patients were asked about their personal details such as age, sex, education, occupation, and residence were noted. Patients were asked to bring the used topical preparations or previous prescriptions. Information regarding irrational combination of topical corticosteroid containing preparations such as source of referrals, their combinations type of steroid abused, potency of steroid, duration of therapy, frequency of application, were collected. Detailed history regarding duration of disease, family history as well as any co-morbid conditions were asked. On examination dermatological signs of steroid abuse such as atrophy, striae, telengiectasia and other changes were noted. Photographic documentation of patients was done with their consent participated in the study. Diagnosis was made clinically and confirmed by potassium hydroxide (KOH)mount. Fungal culture was done in all cases

Results

In our study a total of 100 cases were enrolled out of which 45 cases were excluded due to irregular follow up.

Table 1

Age and gender distribution of the study patients

Age (in years)

Male(N)

%

Female(N)

%

Total

%

0 – 14

05

20

07

23.3

12

21.81

15 – 30

08

32

08

26.7

16

29.09

31 – 50

06

24

08

26.7

14

25.45

>50

06

24

07

23.3

13

23.63

Total

25

100

30

100

55

100

Table 1 Shows that, the most common age group in which ICSP abuse were more include 15-30 years in 16 patients (29.09%) followed by 31-50 years in 14 patients (25.45%). Females(54.54%) predominated over males(45.45%) with male: female ratio was 0.83:1.

Table 2

Complaints

Complaints

Number

%

Itching

46

83.64

Darkness

05

9.09

Burning

02

3.63

Dryness

02

3.63

Total

55

100

Table 2 Shows that the most common complaint was Itching in 46 patients (83.64%).

Table 3

Duration of the disease

Duration

Number

%

0 – 1 Month

15

27.3

1 – 2 Months

07

12.7

3 – 6 Months

21

38.2

7 – 12 Months

02

3.6

> 12 Months

10

18.2

Total

55

100

The duration of the disease is presented in Table 3. The major disease duration was 3-6 months in 21 patients (38.2%).

Table 4

Clinical diagnosis

Parameters

No of patients

%

Tinea corporis

15

27.27

Tinea cruris

13

23.63

Tinea faciei

10

18.18

Tinea corporis+Tinea cruris

12

21.81

Tinea corporis+Tinea cruris+Tinea faciei

6

10.9

Total

55

100

Table 4 Shows that Tinea corporis was the most common clinical diagnosis seen in 15 patients (27.27%) followed by Tinea cruris in 13 patients (23.63%).

Figure 1

Tinea Corporis

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/cc455428-d43c-466c-803c-df9a0cd86ff3image1.png
Figure 2

Tinea faciei

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/cc455428-d43c-466c-803c-df9a0cd86ff3image2.png
Figure 3

Tinea corporis et cruris

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/cc455428-d43c-466c-803c-df9a0cd86ff3image3.png
Figure 4

Tinea corporis

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/cc455428-d43c-466c-803c-df9a0cd86ff3image4.png
Table 5

The Source of referral of ICSP

Indications

Number

%

Self /Over the counter (OTC)

32

58.18

Friends

7

12.72

General practictioner

6

10.9

Physician

4

7.27

Chemist

3

5.45

Paediatrician

2

3.63

Gynaecologist

1

1.81

Total

55

100

Table 5 Shows that the commonest source of referral of ICSP was Over the counter(OTC) in 32 patients (58.18%)

Table 6

Irrational combinations used by the patients

Irrational combinations

N (%)

Duration N (%)

Frequency N (%)

Side effects N (%)

0-1 month

1-2 months

3-6 months

7-12 months

Once daily

Twice daily

Intermittent

Alternate days

Weekly once

Tinea Incognita

Striae

Atrophy

Acneiform eruptions

Erythema

FDC 2

13(23.6%)

7(25.9%)

1(16.7%)

5(26.3%)

-

4(28.5%)

2(18.2%)

5(26.3%)

1(16.6%)

1(20%)

9(27.3%)

2(20%)

2(33.3%)

-

-

FDC 3

17(30.9%)

7(25.9%)

2(33.4%)

7(36.8%)

1(33.3%)

3(27.2%)

3(27.2%)

7(36.8%)

3(50%)

1(20%)

14(25.45%)

1(10%)

1(16.6%)

1(25%)

-

FDC 4

11(20%)

5(18.5%)

1(16.7%)

4(21.1%)

1(33.3%)

5(35.7%)

1(9.1%)

4(21.1%)

-

1(20%)

5(15.2%)

3(30%)

1(16.6%)

1(25%)

1(50%)

FDC 5

14(25.5%)

8(29.6%)

2(33.4%)

3(15.7%)

1(33.3%)

2(14.2%)

5(35.7%)

3(15.7%)

2(33.3%)

2(40%)

5(15.2%)

4(40%)

2(33.3%)

2(50%)

1(50%)

Total

55(100%)

27(49.1%)

6(10.9%)

19(34.5%)

3(5.5%)

14(25%)

11(20%)

19(34.5%)

6(10.9%)

5(9.1%)

33(60%)

10(18.1%)

6(10.9%)

4(7.2%)

2(3.6%)

Table 6 Shows that most common irrational combination was FDC 3 combination in 17 patients(30.9%) which was used for 0-1 month in 7 patients(25.9%) on an intermittent basis in 7 patients(36.8%) causes most common side effect of Tinea Incognita in 14 patients(25.45%), followed by FDC 5 combination in 14 patients(25.5%) which was used for 0-1 month in 8 patients(29.6%) on twice daily basis in 5 patients(35.7%) causes most common side effect of Tinea Incognita in 5 patients(15.2%)

Table 7

Brand names used by the patients

Brand names

N (%)

Duration N (%)

Frequency N (%)

Side effects N (%)

0-1 month

1-2 months

3-6 months

7-12 months

Once daily

Twice daily

Intermittent

Alternate days

Weekly once

Tinea Incognita

Striae

Atrophy

Acneiform eruptions

Erythema

Betnovate GM

17(30.9%)

7(25.9%)

2(33.4%)

7(36.8%)

1(33.3%)

3(27.2%)

3(27.2%)

7(36.8%)

3(50%)

1(20%)

14(25.45%)

1(10%)

1(16.6%)

1(25%)

-

Dermi 5

14(25.5%)

8(29.6%)

2(33.4%)

3(15.7%)

1(33.3%)

2(14.2%)

5(35.7%)

3(15.7%)

2(33.3%)

2(40%)

5(15.2%)

4(40%)

2(33.3%)

2(50%)

1(50%)

Candid B

11(20%)

5(18.5%)

1(16.7%)

4(21.1%)

1(33.3%)

5(35.7%)

1(9.1%)

4(21.1%)

-

1(20%)

5(15.2%)

3(30%)

1(16.6%)

1(25%)

1(50%)

Fourderm

6(10.9%)

2(7.4%)

-

4(21.1%)

-

2(14.2%)

1(9.1%)

2(10.5%)

-

1(20%)

5(15.2%)

1(10%)

-

-

-

Panderm plus

5(9.1%)

3(11.1%)

1(16.7%)

1(5.2%)

-

1(7.1%)

1(9.1%)

2(10.5%)

1(16.6%)

-

2(6.1%)

1(10%)

2(33.3%)

-

-

Halovate S

2(3.7%)

2(7.4%)

-

-

-

1(7.1%)

-

1(5.2%)

-

-

2(6.1%)

-

-

-

-

Total

55(100%)

27(49.1%)

6(10.9%)

19(34.5%)

3(5.5%)

14(25%)

11(20%)

19(34.5%)

6(10.9%)

5(9.1%)

33(60%)

10(18.1%)

6(10.9%)

4(7.2%)

2(3.6%)

Table 7 Shows that most common brand name abused was Betnovate GM in 17 patients (30.9%) which was used for 0-1 month in 7 patients(25.9%) on an intermittent basis in 7 patients(36.8%) causes most common side effect of Tinea Incognita in 14 patients(25.45%), followed by Dermi 5 in 14 patients(25.5%) which was used for 0-1 month in 8 patients(29.6%) on twice daily basis in 5 patients(35.7%) causes most common side effect of Tinea Incognita in 5 patients(15.2%).

Table 8

Topical corticosteroid used by the patients

Name of steroid

N (%)

Duration N (%)

Frequency N (%)

Side effects N (%)

0-1 month

1-2 months

3-6 months

7-12 months

Once daily

Twice daily

Intermittent

Alternate

days

Weekly

once

Tinea

Incognita

Striae

Atrophy

Acneiforme

ruptions

Erythema

Clobetasol propionate 0.05%

25

(45.45%)

13

(48.1%)

3

(50%)

8

(4.2%)

1

(33.3%)

5

(35.7%)

7

(63.63%)

5

(26.31%)

3

(50%)

3

(60%)

12

(36.36%)

6

(60%)

3

(50%)

2

(50%)

1

(50%)

Betamethasone valerate 0.1%

17

(30.9%)

7

(25.9%)

2

(33.3%)

7

(36.8%)

1

(33.3%)

3

(27.2%)

3

(27.2%)

7

(36.8%)

3

(50%)

1

(20%)

14

(25.45%)

1

(10%)

1

(16.6%)

1

(25%)

-

Beclomethasone dipropionate 0.025%

11

(20%)

5

(18.5%)

1

(16.7%)

4

(21.1%)

1

(33.3%)

5

(35.7%)

1

(9.1%)

4

(21.1%)

-

1

(20%)

5

(15.2%)

3

(30%)

1

(16.6%)

1

(25%)

1

(50%)

Halobetasol propionate 0.05%

2

(3.6%)

2

(7.4%)

-

-

-

1

(7.1%)

-

1

(5.2%)

-

-

2

(6.1%)

-

-

-

-

Total

55

(100%)

27

(49.1%)

6

(10.9%)

19

(34.5%)

3

(5.5%)

14

(25%)

11

(20%)

19

(34.5%)

6

(10.9%)

5

(9.1%)

33

(60%)

10

(18.1%)

6

(10.9%)

4

(7.2%)

2

(3.6%)

Table 8 Shows that clobetasol propionate 0.05% was the most commonly abused steroid in 25 patients(45.45%) which was used for 0-1 month in 13 patients(48.1%) on an twice daily basis in 7 patients(63.63%) causes most common side effect of Tinea Incognita in 12 patients(36.36%), followed by Betamethasone valerate 0.1% in 17 patients(30.9%) which was used for 0-1 month in 7 patients(36.8%) on an intermittent basis in 7 patients(36.8%) causes most common side effect of Tinea Incognita in 14 patients(25.45%).

Figure 5

List of Irrational combination of topical corticosteroid containing preparations

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/cc455428-d43c-466c-803c-df9a0cd86ff3image5.png
Table 9

Investigations

Investigations

Positive

Negative

Potassiumhydroxide mount (n=55)

25(45.45%)

30(54.55%)

Fungal culture(n=55)

12(21.81%)

43(79.19%)

Table 9 Shows that Potassium hydroxide mount was positive in 25 patients (45.45%). Fungal culture was done in all patients and 12 patients (21.81%) showed growth.

Table 10

Organism isolated

Organism

N

%

No growth

43

79.19

Trichophyton rubrum

7

12.72

Trichophyton mentagrophytes

3

5.45

Trichophyton tonsurans

1

1.81

Epidermophyton flocculosum

1

1.81

Total

55

100

Organism isolated is presented in the Table 10. The most common organism isolated was Trichophyton rubrum in 7 patients(12.72%), and Trichophyton mentagrophytes in 3 patients (5.45%)

Figure 6

KOH mount

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/cc455428-d43c-466c-803c-df9a0cd86ff3image6.png
Figure 7

Trichophyton rubrum

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/cc455428-d43c-466c-803c-df9a0cd86ff3image7.png

Discussion

There is a rising epidemic of superficial fungal infections in India. Dermatophyte infection is more common in India due to hot and humid climate, low hygiene, poor access to water, overcrowding, high interpersonal contact. Dermatophyte infection become resistant and difficult to treat because of the rising trend of misuse of potent topical steroids by medical and non medical fraternities including misuse in the form of self use. There is wide variety of irrational topical formulations available in India containing ultra high potency steroids in combination with antifungal and antibacterial. The commonest formulation available is a combination of clobetasol propionate 0.05%, ornidazole 2.0%, terbinafine hydrochloride 1.0% and ofloxacin 0.75%.3Ives and Marks in 1968 coined the term Tinea Incognito but later in 2002 Houlbar and Male pointed out the grammatical error but has been sadly ignored. 4

Females (54.54%) predominated males in our study .Whereas male predominated female in a study conducted by Lakhani J et al,3 Thakur R et al, 5 Kothiwala R et al. 6 This discordance in our study is because of inhibition of female to go to hospital particularly in private parts and so they purchased the easily available over the counter preparation and come to the hospital once it become severe. Most common age group was 15-30 years (29.09%).This was in concordance with the study conducted by Thakur R et al, 5 Kothiwala R et al, 6 Most of them resides in rural areas(45.45%). This was in concordance with the study conducted by Lakhani J et al. 3 Most common duration of disease in our study was 3-6 months(38.2%). This was in concordance with the study conducted by Lakhani J et al. 3 Most common source of referral was over the counter (58.18%). This was in concordance with the study conducted by Kothiwala R et al.6 Most common irrational combination was FDC 3 combinations(30.9%) showing that FDC 3 combination drugs were freely available in market. Paucity of literature regarding the Irrational combination of topical corticosteroid containing preparations. Most common brand name was Betnovate GM(30.9%) in our study. Its composition was Betamethasone valerate 0.1%, Gentamycin 0.1%, Miconazole nitrate 2.0%. Whereas the most common brand name was Betnovate in a study conducted by Bains P. 7 Most common steroid used was clobetasol propionate 0.05% (45.5%). Most common duration of therapy was < 1 months (49.1%). Whereas it is more than or equal to 1 month in a study conducted by Kothiwala R et al. 6 Tinea Incognita (60%) was the most common side effect encountered in our study. Whereas it was striae in a study conducted by Lakhani J et al.3Most common KOH and culture results were negative i.e 54.55% and 78.18% due to repeated application of topical steroid combination preparations. Whereas KOH and culture results were positive in study conducted by Thakur R et al. 5 Most common organism isolated was Trichophyton rubrum (12.72%) in our study. Whereas Trichophyton interdigitale was the most common organism isolated in a study conducted by Thakur R et al. 5

Conclusion

Misuse of irrational combination of topical steroid formulations in dermatophyte infections can lead to untowards adverse effects like tinea incognita, atrophy,acneiform eruptions etc as well as chronicity. Thus the irrational FDC (Combination of topical antifungal, antibacterial, steroid) and various others available in the market freely should be banned by Drug Controller General of India(DCGI) and state licensing authorities to curb the epidemic of steroid modified dermatophytosis.

Limitations

This is a hospital based small scale study might not be a true problem in the community. Hence this study could not be generalized to entire population.

Source of Funding

No financial support was received for the work within this manuscript.

Conflict of Interest

The authors declare they have no conflict of interest.

References

1 

A Coondoo M Phiske S Verma K Lahiri Side-effects of topical steroids: A long overdue revisitIndian Dermatol Online J2014544162510.4103/2229-5178.142483

2 

A K Mishra D Saraswat Topical Corticosteroid Abuse in DermatologyIOSR J Dent Med Sci20161507110410.9790/0853-15079110114

3 

J S Lakani F Bilimoria J Lakani Adverse effect of steroid use in dermatophyte infections: a cross sectional studyJ Integr Health Sci201752638

4 

S B Verma A closer look at the term ‘tinea incognito’. A factual as well as grammatical inaccuracyIndian J Dermatol20176221920

5 

R Thakur A S Kalsi P Kushwaha Epidemiology of corticosteroid-modified tinea: study of 100 cases in a rural tertiary care teaching hospital of Western Uttar Pradesh IndiaJ Dermat Cosmetol201825649

6 

Niraj Bohara Hot Trends of Steroid modified tinea at tertiary care hospital in IndiaInt Multispeciality J Health 20183263710.29187/jscmt.2018.29

7 

P Bains Topical corticosteroid abuse on face: a clinical study of 100 patientsInt J Res Dermatol20162340510.18203/issn.2455-4529.intjresdermatol20163105



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

  • Article highlights
  • Article tables
  • Article images

View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.ijced.2020.064


Article Metrics






Article Access statistics

Viewed: 2795

PDF Downloaded: 688



Medical Abbreviation List